Business Development
Find out the invaluable steps you can take to develop your business.
Access resources on new best practices and case studies on business development, strategy, advertising and marketing for the pharmaceutical, biotechnology and healthcare sectors.
What healthcare professionals want from pharma
April 23 by Pharmaceuticals & Biotechnology EditorMeghan Oates-Zalesky discusses why relationship building, efficiency and simplicity are so crucial
What's next for CRISPR? Cas9, Cas3 and beyond
April 16 by Pharma IQInternational researchers have developed a new CRISPR tool, Cas3, likened to a "DNA shredder with a motor"
A Dose of Creativity: How Pharmaceutical Companies Are Changing the Way They Advertise
March 25 by Pharmaceuticals & Biotechnology EditorRik Haslam, executive creative partner at Brandpie, gives an analysis of the latest changes in pharmaceutical advertising
Prostate cancer in Scotland: an evolutionary journey
March 25 by Pharmaceuticals & Biotechnology EditorKaren Walker, Clinical Nurse Specialist at Edinburgh Cancer Center shares this case study
Register Now for FREE!
January 16 by Pharma IQ12th - 14th March Online
March 12 by Pharma IQSmartLab Digital: How to achieve Quality and Laboratory Excellence through Digital Continuity
March 29 by Pharma IQA poor culture of data integrity can lead to a multitude of problems across the drug development process. To improve data integrity, sharing and re-use changes must be made. In this webinar, Daniela...
First Biopharma Product Launch in Europe: What it Takes to Succeed
March 12 by L.E.K. ConsultingL.E.K. Consulting share the five key success factors needed for a biopharma launch
The future of single use solutions in bio-manufacturing
February 26 by Pharmaceuticals & Biotechnology EditorWe share our key takeaways from the recent Disposable Solutions in Bio-Manufacturing conference in Amsterdam.
Bristol-Myers to acquire Celgene for $74 billion: Is it time for the M&A biotech boom?
January 08 by Pharma IQBristol-Myers acquisition of Celgene would create a powerful pharma company with leading positions in immune-oncology and the treatment of blood cancers.
UK Pharma ready to pursue deals and acquisitions despite Brexit uncertainty
December 04 by Pharmaceuticals & Biotechnology EditorEY's Capital Confidence Barometer reveals the pharmaceutical industry is still looking to pursue M&A activity in 2019 with bolt on acquisitions and divestments of non-core assets
3 ways the healthcare industry is looking more like Google, Apple and Amazon
November 16 by Pharmaceuticals & Biotechnology EditorAbbott looks at the ways in which healthcare companies are imitating Big Tech